2.10
Recherche biopharmaceutique : les bases des études cliniques
Les études biopharmaceutiques constituent un domaine essentiel qui vise à améliorer les méthodes d'administration de médicaments et à affiner les appr…
Les études biopharmaceutiques visent à étudier l’administration de médicaments et l’amélioration des thérapies en utilisant des connaissances interdisciplinaires.
Les études non contrôlées, souvent utilisées pour l’exploration initiale, n’ont pas de groupe témoin, ce qui peut entraîner des biais et des influences externes.
À l’inverse, les études contrôlées utilisent un groupe témoin et intègrent des techniques telles que le placebo, les contrôles historiques, les contrôles croisés ou les contrôles de traitement standard pour réduire les biais.
Pour minimiser davantage les biais, l’insu maintient les participants ou les investigateurs dans l’ignorance du traitement assigné. Cela inclut les études en simple aveugle, en double aveugle et en double factice.
Les facteurs de confusion, causés par des variables externes affectant les résultats de l'étude, sont atténués par une conception de l'étude, une méthodologie et une analyse statistique appropriées, et aident à valider l'étude.
La validité interne porte sur la qualité de l’exécution de l’étude, tandis que la validité externe évalue l’applicabilité des résultats à d’autres populations.
Dans les études cliniques, le calcul du risque permet d’estimer l’association exposition-résultat. Il englobe des mesures telles que les risques absolus et relatifs, la réduction des risques absolus et relatifs, le nombre de traitements, les dangers et le rapport de cotes.
View the full transcript and gain access to JoVE Core videos
Q1: What is the main difference between controlled and non-controlled biopharmaceutical studies?
Non-controlled studies lack a control group, making them susceptible to biases and external influences, though useful for initial exploration. Controlled studies employ control groups and techniques such as placebo, historical, crossover, or standard treatment controls to reduce bias and validate findings more rigorously.
Q2: How does blinding reduce bias in biopharmaceutical research?
Blinding keeps participants or investigators unaware of assigned treatments, preventing biased observations. Single-blind designs hide treatment from participants only, double-blind designs hide it from both participants and investigators, and double-dummy designs use placebos for one treatment while administering the active form of another to maintain blinding across different treatment types.
Q3: What role do confounding variables play in study validity?
Confounding variables are external factors that can affect study outcomes and compromise reliability. Proper study design, meticulous methodology, and statistical analysis mitigate confounding effects. Addressing confounding is essential for establishing internal validity, which assesses the quality of study execution and the experimental design's impact on results.
Q4: How do internal and external validity differ in biopharmaceutical studies?
Internal validity assesses the quality of study execution and how well the experimental design controls for bias and confounding. External validity gauges whether study findings apply to broader populations and real-world scenarios, ensuring research outcomes hold relevance beyond the immediate study group.
Q5: What measures are used to calculate risk in clinical biopharmaceutical studies?
Risk calculation estimates the exposure-outcome association using measures like absolute and relative risks, absolute and relative risk reduction, treatment numbers, and hazard and odds ratios. These calculations quantify risks associated with specific interventions, providing insights into treatment benefits and drawbacks to guide clinical decisions.
Q6: Why is statistical analysis important for addressing confounding in biopharmaceutical research?
Statistical analysis helps validate study findings by identifying and controlling for confounding variables that could distort results. Advanced statistical methods work alongside proper study design and methodology to isolate the true effect of treatments, strengthening the reliability of conclusions drawn from biopharmaceutical studies.
Q7: What interdisciplinary knowledge supports biopharmaceutical study design?
Biopharmaceutical studies integrate diverse fields to enhance drug delivery methods and refine therapeutic approaches. This interdisciplinary foundation informs the selection of appropriate study designs, control mechanisms, blinding techniques, and statistical methods needed to produce reliable, valid research that advances pharmaceutical science and patient care.